D
Dan Tong
Researcher at Medical University of Vienna
Publications - 43
Citations - 1585
Dan Tong is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Cancer & Ovarian cancer. The author has an hindex of 23, co-authored 41 publications receiving 1474 citations. Previous affiliations of Dan Tong include University of Vienna.
Papers
More filters
Journal ArticleDOI
PROGINS receptor gene polymorphism is associated with endometriosis
TL;DR: Investigation of the association between the 306-base pair insertion polymorphism in intron G of the progesterone receptor (PROGINS) and endometriosis in white persons found PROGINS appears to be associated with endometRIosis inwhite persons.
Journal ArticleDOI
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
Eva Obermayr,Eva Obermayr,Fátima Sánchez-Cabo,Muy-Kheng Tea,Christian F. Singer,Michael Krainer,Michael B. Fischer,Jalid Sehouli,Alexander Reinthaller,Reinhard Horvat,Georg Heinze,Dan Tong,Robert Zeillinger,Robert Zeillinger +13 more
TL;DR: The panel of six genes was found superior to EpCAM and hMAM for the detection of circulating tumor cells in the blood of breast cancer, and they may serve as potential markers for CTC derived from endometrial, cervical, and ovarian cancers.
Journal ArticleDOI
Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer
Dan Tong,Klaus Czerwenka,Georg Heinze,Martin Ryffel,Eva Schuster,Armin Witt,Sepp Leodolter,Robert Zeillinger +7 more
TL;DR: The gene expression of KLf5 is directly correlated with cell proliferation in vivo and is a prognostic factor for patients with breast cancer, and patients with higher KLF5 expression have shorter disease-free survival and overall survival than patients with lower KLF 5 expression.
Journal Article
Vascular Endothelial Growth Factor Splice Variants and Their Prognostic Value in Breast and Ovarian Cancer
Margit Stimpfl,Dan Tong,Barbara Fasching,Eva Schuster,Andreas Obermair,Sepp Leodolter,Robert Zeillinger +6 more
TL;DR: In this article, the Vascular endothelial growth factor (VEGF) is a promotor for tumor angiogenesis, and is known to be elevated in breast and ovarian cancers.
Journal ArticleDOI
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Nicole Concin,Gerda Hofstetter,A Berger,Adriana Gehmacher,Daniel Reimer,Rafał Watrowski,Dan Tong,Eva Schuster,Lukas Hefler,Kurt Heim,Elisabeth Mueller-Holzner,Christian Marth,Ute M. Moll,Alain G. Zeimet,Robert Zeillinger +14 more
TL;DR: The first clinical evidence that dominant-negative p73 isoforms contribute to drug resistance in vivo is provided, underscoring the importance of a p53-p73 cross-talk.